![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Gedeon Richter Plc Budapest Hu, based in Hungary, is a pharmaceutical company.
One of their significant offerings is Vinblastine Sulfate, New Process, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2013-352 - Rev 00
This Chemical Type CEP, issued on December 21, 2015, remains in force until October 29, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 748 associated with this CEP further emphasizes